Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BAG family molecular chaperone regulator 4 (BAG4, also known as Silencer of death domains or SODD) is a member of the BAG protein family that acts as a co-chaperone and regulatory protein in human cells. It contains a C-terminal BAG domain that interacts with Hsc70/Hsp70 heat shock proteins, inhibiting their chaperone activity by promoting substrate release[1][3][6]. BAG4 is also known for binding to and masking the death domains of tumor necrosis factor receptor type 1 (TNF-R1) and death receptor-3 (DR3), thereby inhibiting constitutive or ligand-independent signaling and negatively regulating downstream apoptotic pathways[1][3][5][6]. Its anti-apoptotic role has been associated with cancer progression, metastasis, and cell survival, particularly through activation of proliferative survival pathways such as PI3K/AKT/NF-κB[4]. There are currently no established drugs directly targeting BAG4, and clinical biomarkers or safety issues specific to this protein have not been established in the current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BAG family molecular chaperone regulator 4 (BAG4).